首页> 中文期刊> 《现代中西医结合杂志》 >蓬草除痹汤对类风湿关节炎免疫调节作用的实验研究

蓬草除痹汤对类风湿关节炎免疫调节作用的实验研究

         

摘要

目的:观察蓬草除痹汤( PCCB)对Ⅱ型胶原诱导关节炎( CIA)大鼠模型外周血中细胞因子IL-17、IL-1β、TNF-α及T细胞亚群CD4+T、CD8+T、CD4+T/CD8+T的干预作用,探讨PCCB治疗类风湿关节炎( RA)的抗炎免疫作用机制。方法建立CIA大鼠模型,随机分为PCCB组、雷公藤组、空白组及模型组,连续给药28 d,采用酶联免疫吸附( ELISA)法、流式细胞术评价PCCB对CIA大鼠关节炎指数(AI)及大鼠血清IL-17、IL-1β、TNF-α和CD4+T、CD8+T、CD4+T/CD8+T表达的影响。结果治疗28 d后,PCCB组、雷公藤组关节肿胀度及AI显著改善(P均<0.01);血清IL-17、IL-1β、TNF-α水平明显降低(P均<0.01);CD4+T降低,CD8+T升高,CD4+T/CD8+T显著降低,且PCCB组的抑制作用明显优于雷公藤组(P<0.05)。结论 PCCB能有效改善CIA大鼠关节炎指数,下调大鼠血清中致炎因子IL-17、IL-1β、TNF-α的水平,调节大鼠血清中CD4+T、CD8+T及CD4+T/CD8+T 比例,这可能是PCCB治疗RA的主要机制,为临床应用及进一步研究奠定了基础。%Objective It is to observe the intervention effect on cytokine of IL -17 , IL-1β, TNF-αand T-lymphocyte subset of CD4 +T,CD8 +T and CD4 +T/CD8 +T in peripheral blood of rats with collagen -induced arthritis Ⅱ( CIA) treated by the Peng Cao rheumatism -syndrome eliminating decoction ( PCCB, abbreviation for the decoction's Chinese name: Peng Cao Chu Bi ) , and to explore its mechanism of immune anti -inflammatory action .Methods CIA rat models were established and randomly divided them into 4 groups:PCCB group , tripterygium glycosides group , blank group and model group , and all the groups were treated for 28 days.Enzyme-linked immunosorbent assay (ELISA) and flow cytometry were used to evaluate the effects on arthritis index ( AI) and on the expression levels of IL -17 , IL-1βand TNF-αand T-lymphocyte subset of CD4 +T,CD8 +T and CD4 +T/CD8 +T in serum of CIA rats treated by PCCB .Results After 28 days'treatment, compared with model group, the AI of the rats in the PCCB and TG groups were significantly improved (P<0.01), the levels of IL-17, IL-1βand TNF-αin serum were reduced (P<0.01), CD4 +were reduced, CD8 +increased (P<0.01) and CD4 +T/CD8 +T reduced obviously (P<0.05), while the inhibiting effect in PCCB group were superior obviously to that in TG group (P<0. 05).Conclusion PCCB could effectively improve the AI of CIA rats , reduce the level of pro-inflammatory cytokine of IL -1, IL-1βand in serum, regulate the ratio of CD4 +T,CD8 +T and CD4 +T/CD8 +T in serum of the rats.That might suggest a key mechanism to remedy RA by PCCB , which may lay a foundation of clinical application for RA treatment .

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号